Cna Financial Corp Relay Therapeutics, Inc. Transaction History

Cna Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$18.07 - $31.37 $94,867 - $164,692	-5,250 Reduced 33.34%	10,499 $235,000
Q2 2022 Aug 09, 2022	BUY	$13.31 - $34.88 $2,662 - $6,976	200 Added 1.29%	15,749 $264,000
Q1 2022 May 10, 2022	SELL	$20.26 - $32.36 $8,914 - $14,238	-440 Reduced 2.75%	15,549 $465,000
Q4 2021 Feb 11, 2022	BUY	$26.0 - $37.03 $82,940 - $118,125	3,190 Added 24.92%	15,989 $491,000
Q3 2021 Nov 12, 2021	BUY	$29.75 - $37.99 $26,477 - $33,811	890 Added 7.47%	12,799 $404,000
Q2 2021 Aug 12, 2021	BUY	$27.5 - $38.19 $29,150 - $40,481	1,060 Added 9.77%	11,909 $436,000
Q1 2021 May 14, 2021	BUY	$32.52 - $61.53 $85,625 - $162,008	2,633 Added 32.05%	10,849 $375,000
Q4 2020 Feb 12, 2021	BUY	$35.51 - $54.03 $50,424 - $76,722	1,420 Added 20.89%	8,216 $341,000
Q3 2020 Nov 12, 2020	BUY	$32.81 - $45.1 $222,976 - $306,499	6,796 New	6,796 $289,000

204

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $537M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.